middle.news
How Algorae’s New Deal with Dr. Reddy’s Could Transform Australian Cancer Care
9:07am on Thursday 27th of November, 2025 AEDT
•
Pharmaceuticals
Read Story
How Algorae’s New Deal with Dr. Reddy’s Could Transform Australian Cancer Care
9:07am on Thursday 27th of November, 2025 AEDT
Key Points
Distribution agreement signed with Dr. Reddy’s Laboratories Ltd
First shipment of Capecitabine expected in December 2025
Partnership enhances Algorae’s commercial footprint in oncology
Ongoing R&D collaborations at Peter MacCallum Cancer Centre
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Algorae Pharmaceuticals (ASX:1AI)
OPEN ARTICLE